2007 Annual Report - Foundation for the National Institutes of Health

Collaborative Summit on
Breast Cancer Research
Surveying the array of funders, researchers, advocates, pharmaceutical industry
representatives, regulators, and policymakers engaged in the fight against breast cancer,
the Avon Foundation turned to the Foundation for NIH to convene a summit to
foster collaboration among these entities.
The Foundation for NIH brought together leaders from 27 funding organizations
and advocacy groups and a host of other experts at a productive meeting in November
with special keynote speaker Paula Zahn. Despite their varying approaches, philosophies,
and programs, participants engaged in frank and open dialogue about
how best to advance toward their ultimate common goal of eradicating breast
cancer. There was consensus on the need to better utilize resources—by identifying
funding gaps and opportunities, and eliminating barriers and redundancies.
Outcomes included the formation of a “National Breast Cancer Planning
Committee” to periodically review the breast cancer landscape and national
agenda, a common database on grant awards, and a public report about how
donations are used.
“This Summit was a critical step toward
identifying, analyzing, and eventually
overcoming all the barriers that stand
between where we are now and the
eradication of breast cancer. The
researchers of our nation and the world
Paula Zahn,
Keynote Speaker
The Honorable
John Edward Porter,
Vice Chairman,
Foundation for NIH
General Session
are counting on the united dedication of
organizations, governments, corporations,
and individuals to this mission.”
Summit Organizers:
National
Cancer
Institute
T h e
Breast
Cancer
Research
Foundation
—Larry Norton, M.D.
Deputy Physician-in-Chief,
Breast Cancer Programs at
Memorial Sloan-Kettering
Cancer Center
PANTONE
287 (50%TINT)
PANTONE
BLACK
CMYK: 50,34.5,0,5.5
Foundation for the National Institutes of Health www.fnih.org | 15